Krensavage Asset Management’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$86K Buy
2022
Q2
$146K Buy
2022
Q1
$149K Sell
2021
Q4
$186K Buy
2021
Q3
$208K Sell
2021
Q2
$252K Buy
2021
Q1
$306K Buy
2020
Q4
$330K Buy